RA
OPK icon

Royce & Associates’s Opko Health OPK Stock Holding History

Royce & Associates’s Portfolio OPK Stock Details OPK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-521,525
Closed -$4.39M – 1162
2015
Q3 		$4.39M Buy
+521,525
New +$6.9M 0.02% 678

Other funds holding OPK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
MTWSIF
Mivtachim The Workers Social Insurance Fund Tel Aviv, Israel $759M AUM 84.08% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royce & Associates's OPK Position: Q4 2015 in Review

Royce & Associates sold out of Opko Health (OPK) in Q4 2015, closing a stake of 521,525 shares — an estimated $4.39M sold.

Royce & Associates first reported a position in OPK in Q3 2015 and held it in 1 quarter. The position peaked at $4.39M in Q3 2015. 273 funds tracked by Wall St. Rank hold OPK as of Q4 2015.

  • Royce & Associates reported no remaining Opko Health position as of Q4 2015 after selling out during the quarter.
  • Royce & Associates sold 521,525 Opko Health shares in Q4 2015, an estimated $4.39M.
  • Royce & Associates first reported a position in Opko Health in Q3 2015 and held it in 1 quarter.
  • Royce & Associates's Opko Health position peaked at $4.39M in Q3 2015.
  • 273 funds tracked by Wall St. Rank held Opko Health as of Q4 2015.

Based on Royce & Associates's 13F filing for Q4 2015, filed 9 Feb 2016.